538 related articles for article (PubMed ID: 15964714)
1. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver.
Kerr T; Marsh D; Li K; Montaner J; Wood E
Drug Alcohol Depend; 2005 Dec; 80(3):329-35. PubMed ID: 15964714
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
[TBL] [Abstract][Full Text] [Related]
3. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users.
Kerr T; Fairbairn N; Tyndall M; Marsh D; Li K; Montaner J; Wood E
Drug Alcohol Depend; 2007 Feb; 87(1):39-45. PubMed ID: 16959438
[TBL] [Abstract][Full Text] [Related]
4. HIV risks associated with incarceration among injection drug users: implications for prison-based public health strategies.
Werb D; Kerr T; Small W; Li K; Montaner J; Wood E
J Public Health (Oxf); 2008 Jun; 30(2):126-32. PubMed ID: 18387974
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with geographic migration among a cohort of injection drug users.
Rachlis BS; Hogg RS; Wood E; Li K; Kerr T
Health Place; 2008 Sep; 14(3):536-43. PubMed ID: 18410717
[TBL] [Abstract][Full Text] [Related]
6. Predictors of methadone maintenance treatment utilization in a multisite cohort of illicit opioid users (OPICAN).
Fischer B; Cruz MF; Patra J; Rehm J
J Subst Abuse Treat; 2008 Apr; 34(3):340-6. PubMed ID: 17614236
[TBL] [Abstract][Full Text] [Related]
7. A longitudinal investigation into excess risk for blood-borne infection among young injection drug users (IUDs).
Miller CL; Strathdee SA; Li K; Kerr T; Wood E
Am J Drug Alcohol Abuse; 2007; 33(4):527-36. PubMed ID: 17668338
[TBL] [Abstract][Full Text] [Related]
8. Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility.
Milloy MJ; Kerr T; Mathias R; Zhang R; Montaner JS; Tyndall M; Wood E
Am J Drug Alcohol Abuse; 2008; 34(4):499-509. PubMed ID: 18584579
[TBL] [Abstract][Full Text] [Related]
9. Methadone maintenance treatment: a protective factor for cocaine injection in a street-recruited cohort of heroin users.
Bravo MJ; Llorens N; Barrio G; Brugal MT; Santos S; Sordo L; de la Fuente L;
Drug Alcohol Depend; 2010 Nov; 112(1-2):62-8. PubMed ID: 20591582
[TBL] [Abstract][Full Text] [Related]
10. Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection.
Dolan KA; Shearer J; White B; Zhou J; Kaldor J; Wodak AD
Addiction; 2005 Jun; 100(6):820-8. PubMed ID: 15918812
[TBL] [Abstract][Full Text] [Related]
11. Effect of methadone treatment on incarceration rates among injection drug users.
Werb D; Kerr T; Marsh D; Li K; Montaner J; Wood E
Eur Addict Res; 2008; 14(3):143-9. PubMed ID: 18552490
[TBL] [Abstract][Full Text] [Related]
12. Barriers and facilitators to methadone maintenance therapy use among illicit opiate injection drug users in Vancouver.
Callon C; Wood E; Marsh D; Li K; Montaner J; Kerr T
J Opioid Manag; 2006; 2(1):35-41. PubMed ID: 17319116
[TBL] [Abstract][Full Text] [Related]
13. Alcohol and cocaine use and abuse among opioid addicts engaged in a methadone maintenance treatment program.
Maremmani I; Pani PP; Mellini A; Pacini M; Marini G; Lovrecic M; Perugi G; Shinderman M
J Addict Dis; 2007; 26(1):61-70. PubMed ID: 17439869
[TBL] [Abstract][Full Text] [Related]
14. Crystal methamphetamine use associated with non-fatal overdose among a cohort of injection drug users in Vancouver.
Fairbairn N; Wood E; Stoltz JA; Li K; Montaner J; Kerr T
Public Health; 2008 Jan; 122(1):70-8. PubMed ID: 17645904
[TBL] [Abstract][Full Text] [Related]
15. Public injecting among a cohort of injecting drug users in Vancouver, Canada.
DeBeck K; Small W; Wood E; Li K; Montaner J; Kerr T
J Epidemiol Community Health; 2009 Jan; 63(1):81-6. PubMed ID: 18628270
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with client-reported HIV infection among clients entering methadone treatment.
MacGowan RJ; Fichtner RR; Swanson N; Collier C; Kroliczak A; Cole G
AIDS Educ Prev; 1997 Jun; 9(3):205-17. PubMed ID: 9241388
[TBL] [Abstract][Full Text] [Related]
17. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
Ngo HT; Tait RJ; Hulse GK
Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
[TBL] [Abstract][Full Text] [Related]
18. Binge drug use independently predicts HIV seroconversion among injection drug users: implications for public health strategies.
Miller CL; Kerr T; Frankish JC; Spittal PM; Li K; Schechter MT; Wood E
Subst Use Misuse; 2006; 41(2):199-210. PubMed ID: 16393742
[TBL] [Abstract][Full Text] [Related]
19. Attendance, drug use patterns, and referrals made from North America's first supervised injection facility.
Tyndall MW; Kerr T; Zhang R; King E; Montaner JG; Wood E
Drug Alcohol Depend; 2006 Jul; 83(3):193-8. PubMed ID: 16356659
[TBL] [Abstract][Full Text] [Related]
20. Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment.
Dobler-Mikola A; Hättenschwiler J; Meili D; Beck T; Böni E; Modestin J
J Subst Abuse Treat; 2005 Dec; 29(4):259-65. PubMed ID: 16311178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]